GERN logo

GERN
Geron Corp.

21,311
Mkt Cap
$689.42M
Volume
12.2M
52W High
$4.21
52W Low
$1.04
PE Ratio
-9.15
GERN Fundamentals
Price
$1.10
Prev Close
$1.08
Open
$1.11
50D MA
$1.25
Beta
1.18
Avg. Volume
7.2M
EPS (Annual)
-$0.2702
P/B
2.82
Rev/Employee
$336,218.34
Loading...
Loading...
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company was founded by Michael D. West on November 28, 1990 and is headquartered in Foster City, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
229

Frequently Asked Questions

What is Market Cap of Geron Corp.?
What is the 52-week high for Geron Corp.?
What is the 52-week low for Geron Corp.?
What is Geron Corp. stock price today?
What was Geron Corp. stock price yesterday?
What is the PE ratio of Geron Corp.?
What is the Price-to-Book ratio of Geron Corp.?
What is the 50-day moving average of Geron Corp.?
How many employess does Geron Corp. has?

Latest GERN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.